IAG Wealth Partners’s Biogen BIIB Stock Holding History

IAG Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	-$3K	–	364
2020 Q2	$3K	Hold	9	–	–	﹤0.01%	308
2020 Q1	$3K	Hold	9	–	–	﹤0.01%	300
2019 Q4	$3K	Buy	+9	New	+$2.5K	﹤0.01%	338

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

IAG Wealth Partners's BIIB Position: Q3 2020 in Review

IAG Wealth Partners sold out of Biogen (BIIB) in Q3 2020, closing a stake of 9 shares — an estimated $3K sold.

IAG Wealth Partners first reported a position in BIIB in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

IAG Wealth Partners reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
IAG Wealth Partners sold 9 Biogen shares in Q3 2020, an estimated $3K.
IAG Wealth Partners first reported a position in Biogen in Q4 2019 and held it in 3 quarters.
IAG Wealth Partners's Biogen position peaked at $3K in Q2 2020.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on IAG Wealth Partners's 13F filing for Q3 2020, filed 11 Feb 2021.